Powered by

Stilla Technologies completes (EURO)16 Million ($18 Million) Series A financing to commercialize its novel digital PCR system and develop clinical applications

Nov 20, 2018 - PR Newswire

PR Newswire

Stilla Technologies, the European provider of pioneering digital PCR solutions for high precision genetic analysis, announced today the successful completion of a Series A financing round of 16 million euros ($18 Million) led by Illumina Ventures, with participation from Kurma Partners, LBO France, BNP Paribas Développement, Paris Saclay Seeds AND Idinvest Partners. As part of the financing, Nick Naclerio (Illumina Ventures), Philippe Peltier (Kurma Partners) and Philippe Cham...